Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the "Company" or "Werewolf"), an innovative biopharmaceutical company pioneering the development of therapeutics ...

With its cash cache set to run out by the fourth quarter of this year, Werewolf Therapeutics is prowling the biotech landscape for a deal to keep its pipeline afloat. | With its cash cache set to run ...

Werewolf Therapeutics plans to explore strategic alternatives including a sale. The biopharmaceutical company said Tuesday it would look at a range of options that could include a sale of the company ...

It's been confirmed today that Michael Giacchino, director of Marvel Studios 'Special Presentation Werewolf by Night, will write Werewolf by Night: Blood Moon Rise, a new Marvel comic book hitting ...